Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Other Neutral

High Tide Announces Proactive Steps to Investigate and Address Potential Manipulation of Its Common Shares

High Tide Probes Market Manipulation as Earnings Beat Fails to Lift Shares

By The Northwire Desk — AI Analysis Apr 23, 2026 · 06:00 HITI · 3.54 High Tide Inc.
Executive Summary
  • The most recent release (April 23, 2026) announces a proactive investigation into potential manipulation of common shares following unusual trading patterns.
  • Management observed that over ten consecutive quarters, closing prices frequently dropped on the day following positive earnings releases despite positive after-hours reactions.
  • The company intends to hire forensic investigators and report findings to Canadian and U.S. regulatory authorities if securities law violations are found.
  • This follows a Q1 2026 earnings release (March 17, 2026) that reported record revenue of C$178.3 million (+25% YoY), positive free cash flow of C$2.9 million, and adjusted EBITDA growth of 62%.
  • Historical context shows a pattern where earnings beats (Jan 29, 2026; Mar 17, 2026) were followed by immediate price declines in the provided trading data.
Material Impact
  • The investigation announcement is defensive and administrative rather than operational. It does not alter revenue projections or cash flow fundamentals immediately.
  • However, it validates a persistent negative market sentiment pattern (earnings drops) that has suppressed the stock price despite strong financial performance.
  • For a risk-averse investor, this introduces uncertainty regarding market integrity and liquidity without offering an immediate resolution or catalyst for price appreciation.
  • The news confirms management's awareness of potential short-selling or manipulation but does not guarantee regulatory intervention or price recovery in the near term.
HITI · Price
Company Overview
  • High Tide Inc. operates primarily through its Canna Cabana retail network in Canada and medical cannabis distribution via Remexian Pharma GmbH in Germany.
  • Flagship Project: Expansion of Canna Cabana stores (220 locations as of Q1 2026) and integration of Remexian for European medical market access.
  • Development: Record revenue run-rate exceeding $700 million annualized; transitioning to positive free cash flow generation.
  • Strategic Initiatives: Pursuing U.S. Medicare CBD pilot participation via subsidiary NuLeaf Naturals; exploring UK entry via M&A within 12 months.
Read the original news release →

More from High Tide Inc.

Jun 17, 2026 · 06:00

Remexian distribution partnerships reinforce German growth thesis, but stock has already priced in the catalyst.

M&A / Property Jun 15, 2026 · 16:00

First net income and record EBITDA beat expectations, but same-store sales decline and flat price action suggest skepticism remains.

Earnings Jun 15, 2026 · 15:31

High Tide receives approval for $40M of facilities

Financings Jun 15, 2026 · 06:00

High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario

M&A / Property Jun 10, 2026 · 11:00

Routine store expansion in line with guidance; market remains skeptical as stock drifts lower post-Q1 beat.

Production / Operations May 11, 2026 · 06:00

Insider buying and surging German medical cannabis market share signal conviction as High Tide shores up a Big Five bank credit line.

Production / Operations